Top Biotech Companies By Revenue

Revenue
RevenueEfficiencyMarket RiskExp Return
1REGN Regeneron Pharmaceuticals
14.2 B
(0.05)
 2.03 
(0.11)
2BNTX BioNTech SE
2.75 B
(0.07)
 3.20 
(0.23)
3CPRX Catalyst Pharmaceuticals
491.73 M
 0.05 
 3.20 
 0.17 
4ARDX Ardelyx
333.62 M
 0.09 
 4.52 
 0.41 
5DNA Ginkgo Bioworks Holdings
227.04 M
(0.03)
 7.17 
(0.22)
6TARS Tarsus Pharmaceuticals
182.95 M
(0.02)
 3.54 
(0.08)
7VALN Valneva SE ADR
153.71 M
 0.21 
 5.29 
 1.13 
8ABCL Abcellera Biologics
28.83 M
(0.05)
 4.67 
(0.24)
9GNFT Genfit
28.57 M
(0.01)
 3.36 
(0.04)
10LPCN Lipocine
11.2 M
(0.11)
 4.22 
(0.44)
11CNTA Centessa Pharmaceuticals PLC
6.85 M
(0.02)
 3.61 
(0.06)
12MOLN Molecular Partners AG
4.97 M
(0.08)
 4.04 
(0.34)
13PTN Palatin Technologies
4.49 M
(0.05)
 5.54 
(0.26)
14DYAI Dyadic International
2.9 M
(0.07)
 4.36 
(0.32)
15TCRX Tscan Therapeutics
2.82 M
(0.22)
 4.32 
(0.96)
16SYRE Spyre Therapeutics
886 K
(0.10)
 3.70 
(0.38)
17ERNA Eterna Therapeutics
582 K
 0.06 
 11.24 
 0.69 
18BCDA Biocardia
477 K
 0.09 
 5.77 
 0.50 
19CMRX Chimerix
324 K
 0.21 
 9.89 
 2.12 
20IBIO iBio, Common Stock
225 K
 0.19 
 7.12 
 1.35 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates. Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.